Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C A Jaffe

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Pituitary|November 18, 2000
Reevaluation of conventional pituitary irradiation in the therapy of acromegalyC A Jaffe
Drugs|March 1, 1994
Acromegaly. Recognition and treatmentC A Jaffe, A L Barkan
Endocrinology and Metabolism Clinics of North America|September 1, 1992
Treatment of acromegaly with dopamine agonistsC A Jaffe, A L Barkan
Clinical Pharmacy|October 1, 1993
Amiodarone-induced thyroid dysfunctionU Khanderia, C A Jaffe, V Theisen
The Journal of Clinical Endocrinology and Metabolism|July 14, 1998
Evaluation of the integrity of the hypothalamic-pituitary-adrenal axis by insulin hypoglycemia testE Erturk, C A Jaffe, A L Barkan
Trends in Endocrinology and Metabolism: TEM|April 1, 1997
In vivo Investigation of Hypothalamic Secretory ActivityA L Barkan, C A Jaffe, V Padmanabhan
The Journal of Clinical Investigation|August 1, 1993
Suppression of growth hormone (GH) secretion by a selective GH-releasing hormone (GHRH) antagonist. Direct evidence for involvement of endogenous GHRH in the generation of GH pulsesC A Jaffe, R D Friberg, A L Barkan
The American Journal of Physiology|August 13, 1999
Insulin hypoglycemia and growth hormone secretion in sheep: a paradox revisitedC A Jaffe, B W Huffman, R Demott-Friberg
The Journal of Clinical Investigation|February 15, 1996
Endogenous growth hormone (GH)-releasing hormone is required for GH responses to pharmacological stimuliC A Jaffe, R DeMott-Friberg, A L Barkan
The Journal of Clinical Endocrinology and Metabolism|February 1, 1997
Suppression of growth hormone (GH) hypersecretion due to ectopic GH-releasing hormone (GHRH) by a selective GHRH antagonistC A Jaffe, R DeMott-Friberg, L A Frohman, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Pituitary|November 18, 2000
Reevaluation of conventional pituitary irradiation in the therapy of acromegalyC A Jaffe
Drugs|March 1, 1994
Acromegaly. Recognition and treatmentC A Jaffe, A L Barkan
Endocrinology and Metabolism Clinics of North America|September 1, 1992
Treatment of acromegaly with dopamine agonistsC A Jaffe, A L Barkan
Clinical Pharmacy|October 1, 1993
Amiodarone-induced thyroid dysfunctionU Khanderia, C A Jaffe, V Theisen
The Journal of Clinical Endocrinology and Metabolism|July 14, 1998
Evaluation of the integrity of the hypothalamic-pituitary-adrenal axis by insulin hypoglycemia testE Erturk, C A Jaffe, A L Barkan
Trends in Endocrinology and Metabolism: TEM|April 1, 1997
In vivo Investigation of Hypothalamic Secretory ActivityA L Barkan, C A Jaffe, V Padmanabhan
The Journal of Clinical Investigation|August 1, 1993
Suppression of growth hormone (GH) secretion by a selective GH-releasing hormone (GHRH) antagonist. Direct evidence for involvement of endogenous GHRH in the generation of GH pulsesC A Jaffe, R D Friberg, A L Barkan
The American Journal of Physiology|August 13, 1999
Insulin hypoglycemia and growth hormone secretion in sheep: a paradox revisitedC A Jaffe, B W Huffman, R Demott-Friberg
The Journal of Clinical Investigation|February 15, 1996
Endogenous growth hormone (GH)-releasing hormone is required for GH responses to pharmacological stimuliC A Jaffe, R DeMott-Friberg, A L Barkan
The Journal of Clinical Endocrinology and Metabolism|February 1, 1997
Suppression of growth hormone (GH) hypersecretion due to ectopic GH-releasing hormone (GHRH) by a selective GHRH antagonistC A Jaffe, R DeMott-Friberg, L A Frohman, et al.
Pageof 3